Amna Nawaz
@PBSNewsHour·5.3M subscribers·62.2K videos
FDA approves mRNA flu vaccine for older adults
Posted
August 7, 2026
Views
5,477
Likes
259
Engagement
4.73%
August 7, 2026
5,477
259
4.73%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:43Now PlayingThe same mRNA technology that made the COVID-19 vaccine possible will soon be used in flu vaccines for older Americans.
The FDA has approved a new shot from Moderna called mFlusiva for adults age 50 to 64. The company is also seeking full approval for adults 65 and older.
Compared to traditional shots, mRNA vaccines are quicker to manufacture. Experts say that could help protect against future strains of the flu as they emerge.
The FDA had initially refused to consider Moderna's application amid the Trump administration's heightened scrutiny of vaccines.
Sign up for Here's The Deal with Lisa Desjardins
Subscribe for exclusive content in our newsletters
PBS News podcasts
Stream your PBS favorites with the PBS app
Find more from PBS News at
Subscribe to our YouTube channel
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
